in’t Hout FE, Scheele TN, Westers TM, Alhan C, Duetz C, Cremers EM, Visser-Wisselaar HA, Verbrugge A, Chitu DA, van der Reijden BA, de Graaf AO, van de Loosdrecht AA, Jansen JH. Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients. Haematologica; https://doi.org/10.3324/haematol.2024.286157 [Early view].